ELEPHAS BIOSCIENCES RAISES $40M TO ACCELERATE COMMERCIALIZATION OF ITS LIVE TUMOR PROFILING PLATFORM
Reinvestment from existing backers underscores confidence in Elephas' predictive approach to improving immunotherapy treatment response rates MADISON, Wis., Nov. 6,...